相似文献
1
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Antimicrob Agents Chemother. 2008 Oct;52(10):3823-5. doi: 10.1128/AAC.00026-08. Epub 2008 Jul 21.
2
Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia.
J Antimicrob Chemother. 2010 Mar;65(3):483-9. doi: 10.1093/jac/dkp476. Epub 2010 Jan 12.
3
Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Int J Environ Res Public Health. 2015 May 13;12(5):5177-95. doi: 10.3390/ijerph120505177.
4
Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran.
Sci Rep. 2021 May 5;11(1):9582. doi: 10.1038/s41598-021-88977-z.
5
Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics.
Diagn Microbiol Infect Dis. 2016 Jun;85(2):210-2. doi: 10.1016/j.diagmicrobio.2016.02.020. Epub 2016 Feb 26.
6
Smqnr variants in clinical isolates of Stenotrophomonas maltophilia in Brazil.
Rev Inst Med Trop Sao Paulo. 2013 Nov-Dec;55(6):417-20. doi: 10.1590/S0036-46652013000600008.
7
Detection of the Smqnr quinolone protection gene and its prevalence in clinical isolates of Stenotrophomonas maltophilia in China.
J Med Microbiol. 2012 Apr;61(Pt 4):535-539. doi: 10.1099/jmm.0.037309-0. Epub 2011 Nov 17.
8
Evaluation of the presence of integrons, sul and smqnr genes and the prevalence of antibiotic resistance in Stenotrophomonas maltophilia clinical isolates.
Indian J Med Microbiol. 2024 May-Jun;49:100612. doi: 10.1016/j.ijmmb.2024.100612. Epub 2024 May 17.
9
Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain.
J Bacteriol. 2012 Jul;194(13):3563-4. doi: 10.1128/JB.00602-12.
10
Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.
Microb Drug Resist. 2002 Winter;8(4):245-51. doi: 10.1089/10766290260469499.
引用本文的文献
1
Mutation of Renders Resistant to First-Line Antibiotics Trimethoprim/Sulfamethoxazole and Levofloxacin.
Antibiotics (Basel). 2025 May 28;14(6):550. doi: 10.3390/antibiotics14060550.
2
Genomic and machine learning approaches to predict antimicrobial resistance in .
Microbiol Spectr. 2025 Aug 5;13(8):e0263224. doi: 10.1128/spectrum.02632-24. Epub 2025 Jun 18.
3
Risk factors and clinical characteristics for Stenotrophomonas maltophilia infection in an acute care hospital in Japan: a single-center retrospective study.
J Pharm Health Care Sci. 2025 Mar 28;11(1):24. doi: 10.1186/s40780-025-00429-2.
4
Assessment of airborne bacteria from a public health institution in Mexico City.
PLOS Glob Public Health. 2024 Nov 7;4(11):e0003672. doi: 10.1371/journal.pgph.0003672. eCollection 2024.
5
Novel Qnr Families as Conserved and Intrinsic Quinolone Resistance Determinants in spp.
J Microbiol Biotechnol. 2024 Jun 28;34(6):1276-1286. doi: 10.4014/jmb.2403.03043. Epub 2024 Apr 19.
6
Comparative genomics analysis of strains from a community.
Front Cell Infect Microbiol. 2023 Nov 28;13:1266295. doi: 10.3389/fcimb.2023.1266295. eCollection 2023.
7
Whole-Genome Sequencing-Based Resistome Analysis of Nosocomial Multidrug-Resistant Non-Fermenting Gram-Negative Pathogens from the Balkans.
Microorganisms. 2023 Mar 3;11(3):651. doi: 10.3390/microorganisms11030651.
8
Coming from the Wild: Multidrug Resistant Opportunistic Pathogens Presenting a Primary, Not Human-Linked, Environmental Habitat.
Int J Mol Sci. 2021 Jul 28;22(15):8080. doi: 10.3390/ijms22158080.
9
The Potential of Phage Therapy against the Emerging Opportunistic Pathogen .
Viruses. 2021 Jun 3;13(6):1057. doi: 10.3390/v13061057.
10
Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran.
Sci Rep. 2021 May 5;11(1):9582. doi: 10.1038/s41598-021-88977-z.
本文引用的文献
1
qnr Gene nomenclature.
Antimicrob Agents Chemother. 2008 Jul;52(7):2297-9. doi: 10.1128/AAC.00147-08. Epub 2008 Apr 21.
2
Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants.
Antimicrob Agents Chemother. 2007 Jul;51(7):2650-1. doi: 10.1128/AAC.00070-07. Epub 2007 Apr 23.
3
Origin of plasmid-mediated quinolone resistance determinant QnrA.
Antimicrob Agents Chemother. 2005 Aug;49(8):3523-5. doi: 10.1128/AAC.49.8.3523-3525.2005.
4
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae.
J Antimicrob Chemother. 2005 Sep;56(3):463-9. doi: 10.1093/jac/dki245. Epub 2005 Jul 14.
5
Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV.
Antimicrob Agents Chemother. 2005 Jul;49(7):3050-2. doi: 10.1128/AAC.49.7.3050-3052.2005.
6
Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
Antimicrob Agents Chemother. 2005 Jan;49(1):118-25. doi: 10.1128/AAC.49.1.118-125.2005.
7
Mechanism of plasmid-mediated quinolone resistance.
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5638-42. doi: 10.1073/pnas.082092899. Epub 2002 Apr 9.
8
Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.
Antimicrob Agents Chemother. 2001 Jun;45(6):1879-81. doi: 10.1128/AAC.45.6.1879-1881.2001.
9
Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.
J Clin Microbiol. 2000 Dec;38(12):4305-9. doi: 10.1128/JCM.38.12.4305-4309.2000.
10
Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples.
J Clin Microbiol. 1998 Jul;36(7):1953-8. doi: 10.1128/JCM.36.7.1953-1958.1998.
Zotero 插件